Review Article | Published:

Acting on non-communicable diseases in low- and middle-income tropical countries

Naturevolume 559pages507516 (2018) | Download Citation

Abstract

The classical portrayal of poor health in tropical countries is one of infections and parasites, contrasting with wealthy Western countries, where unhealthy diet and behaviours cause non-communicable diseases (NCDs) such as heart disease and cancer. Using international mortality data, we show that most NCDs cause more deaths at every age in low- and middle-income tropical countries than in high-income Western countries. Causes of NCDs in low- and middle-income countries include poor nutrition and living environment, infections, insufficient taxation and regulation of tobacco and alcohol, and under-resourced and inaccessible healthcare. We identify a comprehensive set of actions across health, social, economic and environmental sectors that could confront NCDs in low- and middle-income tropical countries and reduce global health inequalities.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Wagner, K. H. & Brath, H. A global view on the development of non communicable diseases. Prev. Med. 54, S38–S41 (2012).

  2. 2.

    McKeown, T. The Origins of Human Disease (Blackwell, Oxford, 1988).

  3. 3.

    Omran, A. R. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem. Fund Q. 49, 509–538 (1971).

  4. 4.

    Nugent, R. A chronology of global assistance funding for NCD. Glob. Heart 11, 371–374 (2016).

  5. 5.

    Di Cesare, M. et al. Inequalities in non-communicable diseases and effective responses. Lancet 381, 585–597 (2013).A synthesis of data on global and within-country inequalities in NCDs and their causes, showing that the burden of ill health from most NCDs is higher in poor countries, poor communities and poor people.

  6. 6.

    Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. & Murray, C. J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367, 1747–1757 (2006).

  7. 7.

    World Health Organization (WHO). Global Status Report on Noncommunicable Diseases 2010. http://www.who.int/nmh/publications/ncd_report2010/en/ (WHO, 2011).

  8. 8.

    Bray, F., Jemal, A., Grey, N., Ferlay, J. & Forman, D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol. 13, 790–801 (2012).

  9. 9.

    Kwan, G. F. et al. Endemic cardiovascular diseases of the poorest billion. Circulation 133, 2561–2575 (2016).

  10. 10.

    Ahmad, O. et al. Age Standardization of Rates: a New WHO Standard. http://www.who.int/healthinfo/paper31.pdf (World Health Organization, 2001).

  11. 11.

    Moriyama, I. M. & Gover, M. Heart diseases and allied causes of death in relation to age changes in the population. Public Health Rep. 63, 537–545 (1948). An elegant and pioneering analysis of trends over time in medical causes of death that shows the diversity of trends in deaths from different NCDs.

  12. 12.

    Preston, S. H. & Nelson, V. E. Structure and change in causes of death: an international summary. Popul. Stud. 28, 19–51 (1974).

  13. 13.

    Omran, A. R. A century of epidemiologic transition in the United States. Prev. Med. 6, 30–51 (1977).

  14. 14.

    Mayosi, B. M. in Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th edn (eds Mann, D. L., Zipes, D. P., Libby, P. & Bonow, R. O.) (Elsevier Saunders, Philadelphia 2015).

  15. 15.

    Gordis, L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation 72, 1155–1162 (1985).

  16. 16.

    Ezzati, M. et al. Contributions of risk factors and medical care to cardiovascular mortality trends. Nat. Rev. Cardiol. 12, 508–530 (2015).

  17. 17.

    Karthikeyan, G. & Mayosi, B. M. Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa? Circulation 120, 709–713 (2009).

  18. 18.

    Shaper, A. G. Cardiovascular disease in the tropics. II. Endomyocardial fibrosis. BMJ 3, 743–746 (1972).

  19. 19.

    Ogoina, D. & Onyemelukwe, G. C. The role of infections in the emergence of non-communicable diseases (NCDs): compelling needs for novel strategies in the developing world. J. Infect. Public Health 2, 14–29 (2009).

  20. 20.

    Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2, 634–647 (2014).

  21. 21.

    Gladwin, M. T. Cardiovascular complications and risk of death in sickle-cell disease. Lancet 387, 2565–2574 (2016).

  22. 22.

    Woolsey, T. D. & Moriyama, I. M. Statistical studies of heart diseases; important factors in heart disease mortality trends. Public Health Rep. 63, 1247–1273 (1948).

  23. 23.

    Shaper, A. G. Cardiovascular studies in the Samburu tribe of Northern Kenya. Am. Heart J. 63, 437–442 (1962).

  24. 24.

    Shaper, A. G. Cardiovascular disease in the tropics. IV. Coronary heart disease. BMJ 4, 32–35 (1972).One of a series of four articles that presented carefully collected high-quality data on cardiovascular diseases in low-income tropical countries, especially in Africa, and demonstrated the complexity of their aetiology.

  25. 25.

    Kennelly, B. M., Truswell, A. S. & Schrire, V. A clinical and electrocardiographic study of Kung Bushmen. S. Afr. Med. J. 46, 1093–1097 (1972).

  26. 26.

    Kaplan, H. et al. Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study. Lancet 389, 1730–1739 (2017).

  27. 27.

    Shaper, A. G. Problems and prospects in tropical cardiology. Scott. Med. J. 12, 393–400 (1967).

  28. 28.

    Wild, C. P. The role of cancer research in noncommunicable disease control. J. Natl. Cancer Inst. 104, 1051–1058 (2012).

  29. 29.

    Danaei, G., Vander Hoorn, S., Lopez, A. D., Murray, C. J. & Ezzati, M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366, 1784–1793 (2005).

  30. 30.

    Ezzati, M. & Riboli, E. Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science 337, 1482–1487 (2012).

  31. 31.

    Blackadar, C. B. Historical review of the causes of cancer. World J. Clin. Oncol. 7, 54–86 (2016).

  32. 32.

    Allemani, C. et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385, 977–1010 (2015).

  33. 33.

    Plummer, M. et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob. Health 4, e609–e616 (2016).

  34. 34.

    Marshall, B. J. & Warren, J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311–1315 (1984).The seminal study that established the role of Helicobacter pylori as a cause of lesions that precede stomach cancer, and earned Marshall and Warren the Nobel Prize in Physiology and Medicine.

  35. 35.

    Gersten, O. & Wilmoth, J. R. The cancer transition in Japan since 1951. Demogr. Res. 7, 271–306 (2002).

  36. 36.

    Wingo, P. A. et al. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer 97, 3133–3275 (2003).

  37. 37.

    Howson, C. P., Hiyama, T. & Wynder, E. L. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol. Rev. 8, 1–27 (1986).

  38. 38.

    Vaccarella, S., Lortet-Tieulent, J., Plummer, M., Franceschi, S. & Bray, F. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur. J. Cancer 49, 3262–3273 (2013).

  39. 39.

    Ferro, A. et al. Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur. J. Cancer 50, 1330–1344 (2014).

  40. 40.

    Bruni, L. et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob. Health 4, e453–e463 (2016).

  41. 41.

    Xia, J., Jiang, S. C. & Peng, H. J. Association between liver fluke infection and hepatobiliary pathological changes: a systematic review and meta-analysis. PLoS One 10, e0132673 (2015).

  42. 42.

    World Health Organization (WHO). Global Hepatitis Report 2017. (http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ (WHO, 2017).

  43. 43.

    Pearson-Stuttard, J. et al. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol. 6, e6–e15 (2018).

  44. 44.

    NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387, 1513–1530 (2016).

  45. 45.

    NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 390, 2627–2642 (2017).An analysis of trends in underweight, overweight and obesity for all of the world’s countries using the largest-ever collection anthropometric measurement from nearly 130 million people over four decades.

  46. 46.

    Ezzati, M. & Riboli, E. Behavioral and dietary risk factors for noncommunicable diseases. N. Engl. J. Med. 369, 954–964 (2013).

  47. 47.

    Boseley, S. Threats, bullying, lawsuits: tobacco industry’s dirty war for the African market. The Guardian https://www.theguardian.com/world/2017/jul/12/big-tobacco-dirty-war-africa-market (12 July 2017).

  48. 48.

    World Health Organization (WHO). Global Status Report on Alcohol and Health 2014 (WHO, 2014).

  49. 49.

    Gelband, H. et al. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition. Lancet 387, 2133–2144 (2016).

  50. 50.

    Weatherall, D. J. & Clegg, J. B. Inherited haemoglobin disorders: an increasing global health problem. Bull. World Health Organ. 79, 704–712 (2001).

  51. 51.

    Piel, F. B. et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat. Commun. 1, 104 (2010).A careful analysis that confirmed the role of historical malaria geography as the determinant of the geographical distribution of sickle cell disease.

  52. 52.

    Grosse, S. D. et al. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am. J. Prev. Med. 41, S398–S405 (2011).

  53. 53.

    McGinley, K. F., Tay, K. J. & Moul, J. W. Prostate cancer in men of African origin. Nat. Rev. Urol. 13, 99–107 (2016).

  54. 54.

    Haiman, C. A. et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat. Genet. 43, 570–573 (2011).

  55. 55.

    Popkin, B. M. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am. J. Clin. Nutr. 84, 289–298 (2006).

  56. 56.

    Reddy, K. S. & Yusuf, S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 97, 596–601 (1998).

  57. 57.

    World Health Organization (WHO). Global Report on Urban Health: Equitable Healthier Cities for Sustainable Development. Report No. 9241565276 (World Health Organization, Geneva, 2016).

  58. 58.

    Yusuf, S., Reddy, S., Ôunpuu, S. & Anand, S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104, 2746–2753 (2001).

  59. 59.

    Micha, R. et al. Global, regional and national consumption of major food groups in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys worldwide. BMJ Open 5, e008705 (2015).

  60. 60.

    Danaei, G. et al. The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation 127, 1493–1502 (2013).

  61. 61.

    NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 389, 37–55 (2017).An analysis of four decades of trends in systolic and diastolic blood pressure for all of the world’s countries that showed that low-income countries have some of the highest blood pressure levels in the world, and vice versa.

  62. 62.

    NCD Risk Factor Collaboration (NCD-RisC). Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int. J. Epidemiol. 47, 872–883i (2018).

  63. 63.

    Farzadfar, F. et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 377, 578–586 (2011).

  64. 64.

    Barker, D. J., Winter, P. D., Osmond, C., Margetts, B. & Simmonds, S. J. Weight in infancy and death from ischaemic heart disease. Lancet 2, 577–580 (1989).

  65. 65.

    Victora, C. G. et al. Maternal and child undernutrition: consequences for adult health and human capital. Lancet 371, 340–357 (2008).

  66. 66.

    Ravelli, G. P., Stein, Z. A. & Susser, M. W. Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 295, 349–353 (1976).One of the first studies to show the role of fetal and early life undernutrition as a cause of NCDs and NCD risk factors in adult life.

  67. 67.

    Hales, C. N. & Barker, D. J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35, 595–601 (1992).

  68. 68.

    Bhargava, S. K. et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N. Engl. J. Med. 350, 865–875 (2004).

  69. 69.

    Tanner, J. M. Growth as a mirror of the condition of society: secular trends and class distinctions. Acta Paediatr. Jpn. 29, 96–103 (1987).

  70. 70.

    Tanner, J. M. A History of the Study of Human Growth (Cambridge University Press, Cambridge, 1981).

  71. 71.

    Fogel, R. W. Changes in the Physiology of Aging during the Twentieth Century. NBER Working Paper 11233 (National Bureau of Economic Research, 2005).

  72. 72.

    NCD Risk Factor Collaboration (NCD-RisC). A century of trends in adult human height. eLife 5, e13410 (2016).The first analysis of trends in height in adulthood for all of the countries in the world, that showed the massive worldwide variation in height gain over a period of a century.

  73. 73.

    Stevens, G. A. et al. Trends in mild, moderate, and severe stunting and underweight, and progress towards MDG 1 in 141 developing countries: a systematic analysis of population representative data. Lancet 380, 824–834 (2012).

  74. 74.

    Byrne, A. L., Marais, B. J., Mitnick, C. D., Lecca, L. & Marks, G. B. Tuberculosis and chronic respiratory disease: a systematic review. Int. J. Inf. Dis. 32, 138–146 (2015).

  75. 75.

    Colley, D. G., Bustinduy, A. L., Secor, W. E. & King, C. H. Human schistosomiasis. Lancet 383, 2253–2264 (2014).

  76. 76.

    Roivainen, M. et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 101, 252–257 (2000).

  77. 77.

    Black, R. E. et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 382, 427–451 (2013).

  78. 78.

    Gakidou, E. et al. Improving child survival through environmental and nutritional interventions: the importance of targeting interventions toward the poor. J. Am. Med. Assoc. 298, 1876–1887 (2007).

  79. 79.

    Shaper, A. G. Cardiovascular disease in the tropics. I. Rheumatic heart. BMJ 3, 683–686 (1972).

  80. 80.

    Gakidou, E., Nordhagen, S. & Obermeyer, Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 5, e132 (2008).

  81. 81.

    Chow, C. K. et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. J. Am. Med. Assoc. 310, 959–968 (2013).

  82. 82.

    Mills, K. T. et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 134, 441–450 (2016).

  83. 83.

    Feigin, V. L., Lawes, C. M., Bennett, D. A., Barker-Collo, S. L. & Parag, V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 8, 355–369 (2009).

  84. 84.

    Academy of Medical Sciences (AMA). Multimorbidity: a Priority for Global Health Research. https://acmedsci.ac.uk/policy/policy-projects/multimorbidity (AMA, 2018).

  85. 85.

    World Health Organization (WHO). Global Health Estimates: Deaths by Cause, Age, Sex and Country, 2000–2016 http://www.who.int/healthinfo/global_burden_disease/estimates/en/ (WHO, 2018).

  86. 86.

    Epstein, M. A. Historical background. Phil. Trans. R. Soc. Lond. B 356, 413–420 (2001).

  87. 87.

    Bagaitkar, J., Demuth, D. R. & Scott, D. A. Tobacco use increases susceptibility to bacterial infection. Tob. Induc. Dis. 4, 12 (2008).

  88. 88.

    Lin, H. H., Ezzati, M. & Murray, M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med. 4, e20 (2007).

  89. 89.

    Parry, C., Rehm, J., Poznyak, V. & Room, R. Alcohol and infectious diseases: an overlooked causal linkage? Addiction 104, 331–332 (2009).

  90. 90.

    Rehm, J., Probst, C., Shield, K. D. & Shuper, P. A. Does alcohol use have a causal effect on HIV incidence and disease progression? A review of the literature and a modeling strategy for quantifying the effect. Popul. Health Metr. 15, 4 (2017).

  91. 91.

    Casqueiro, J., Casqueiro, J. & Alves, C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J. Endocrinol. Metab. 16, S27–S36 (2012).

  92. 92.

    Pandrea, I., Happel, K. I., Amedee, A. M., Bagby, G. J. & Nelson, S. Alcohol’s role in HIV transmission and disease progression. Alcohol Res. Health 33, 203–218 (2010).

  93. 93.

    Imtiaz, S. et al. Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease. Eur. Respir. J. 50, 1700216 (2017).

  94. 94.

    Pan, S. C. et al. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol. 3, 323–330 (2015).

  95. 95.

    Harries, A. D. et al. The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int. J. Tuberc. Lung Dis. 15, 1436–1444 (2011).

  96. 96.

    Dye, C. After 2015: infectious diseases in a new era of health and development. Phil. Trans. R. Soc. Lond. B 369, 20130426 (2014).

  97. 97.

    Baris, E. & Ezzati, M. Should interventions to reduce respirable pollutants be linked to tuberculosis control programmes? Br. Med. J. 329, 1090–1093 (2004).

  98. 98.

    Harries, A. D. et al. Diabetes mellitus and tuberculosis: programmatic management issues. Int. J. Tuberc. Lung Dis. 19, 879–886 (2015).

  99. 99.

    Jamison, D. T. et al. Global health 2035: a world converging within a generation. Lancet 382, 1898–1955 (2013).

  100. 100.

    Prabhakaran, D. et al. Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition. Lancet 391, 1224–1236 (2018).

  101. 101.

    Patel, V. et al. Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet 370, 991–1005 (2007).

  102. 102.

    Ruel, M. T. & Alderman, H. Nutrition-sensitive interventions and programmes: how can they help to accelerate progress in improving maternal and child nutrition? Lancet 382, 536–551 (2013).

  103. 103.

    Bhutta, Z. A. et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet 382, 452–477 (2013).

  104. 104.

    Jamison, D. T. et al. Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition. Lancet 391, 1108–1120 (2018).The overview of the work in the Disease Control Priorities study that identified actions and interventions with potential for large impacts on different diseases, including NCDs.

  105. 105.

    Manjomo, R. C. et al. Managing and monitoring chronic non-communicable diseases in a primary health care clinic, Lilongwe, Malawi. Public Health Action 6, 60–65 (2016).

Download references

Acknowledgements

We thank R. Beaglehole, S. Blundell, R. Nugent, F. Piel, M. Parkins and M. Thun for comments and recommendation of background literature.

Reviewer information

Nature thanks F. Assah, P. Byass, B. Singer and the other anonymous reviewer(s) for their contribution to the peer review of this work.

Author information

Affiliations

  1. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK

    • Majid Ezzati
    • , Jonathan Pearson-Stuttard
    •  & James E. Bennett
  2. MRC-PHE Centre for Environment and Health, Imperial College London, London, UK

    • Majid Ezzati
    • , Jonathan Pearson-Stuttard
    •  & James E. Bennett
  3. WHO Collaborating Centre on NCD Surveillance and Epidemiology, Imperial College London, London, UK

    • Majid Ezzati
  4. Department of Information, Evidence and Research, World Health Organization, Geneva, Switzerland

    • Colin D. Mathers

Authors

  1. Search for Majid Ezzati in:

  2. Search for Jonathan Pearson-Stuttard in:

  3. Search for James E. Bennett in:

  4. Search for Colin D. Mathers in:

Contributions

M.E. designed the Review concept and wrote the Review with input from J.P.-S., J.E.B. and C.D.M. J.P.-S. contributed to clinical and epidemiological reviews. J.E.B. and C.D.M. analysed data, and J.E.B. prepared figures.

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to Majid Ezzati.

Supplementary information

  1. Supplementary Figures

    This file contains Supplementary Figures 1-3.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41586-018-0306-9

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.